[Oae-devel] Workshop Announcement: Vaccine & Drug Ontology in the Study of Mechanism and Effect (VDOSME 2012)

[He, Y. <yon...@me...>]

Dear all,

Here it is to announce the Vaccine and Drug Ontology in the Study of Mechanism and Effect (VDOSME 2012) workshop. The VDOSME 2012 workshop will be held in July, 2012, at Medical University of Graz, Austria. It is part of the 2012 International Conference on Biomedical Ontology (ICBO 2012).

Related information can be found at:
http://kr-med.org/icbofois2012/vdosme/
http://kr-med.org/icbofois2012/vdosme/callforpapers.htm
(Paper submission deadline: April 15)
LinkedIn site:
http://www.linkedin.com/groups?about=&gid=4313827&trk=anet_ug_grppro
(Note: You are welcome to join our VDOSME 2012 LinkedIn Group. It's free to join :) )

A related workshop in ICBO 2012:
Workshop Name: Methods for adverse events representation Ontology and Information Model
http://kr-med.org/icbofois2012/adverse_events/

---------------
Summary:

Vaccines and drugs have contributed to dramatic improvements in public health worldwide. Over the last decade, there have been efforts in biomedical ontology that represent various areas associated with vaccines and drugs and which join existing health and clinical terminology systems (e.g., SNOMED, RxNorm, NDF-RT, and MedDRA) in their application to research and clinical data.

The VDOSME 2012 workshop will provide a platform for discussing problems and solutions in the development and application of biomedical ontologies to representing and analyzing vaccines/drugs, vaccine/drug administrations, vaccine/drug-induced immune responses, and similar topics. The workshop will cover:
            Ontology Coverage: Ontologies of vaccines, of drugs, and of studies thereof.
            Scope of Interest: Representations and analyses of vaccine and drug formation and preparation, administration, mechanisms, and effects based on such ontologies.
 Examples of biomedical subject matter in the scope of this workshop: vaccine/drug components (e.g., vaccine antigens, drug active ingredients, and adjuvants), administration details (e.g., dosage, administration route, and frequency), gene immune responses and pathways, drug-drug or drug-food interactions.

We will also focus on computational methods used to study these, for example, literature mining of vaccine/drug-gene interaction networks, meta-analysis of host immune responses, and time event analysis of vaccine/drug effects.
---------------

It would be appreciated if you could distribute this announcement to any people or groups who might be interested. Thanks!

Oliver

Yongqun "Oliver" He, DVM, PhD
Associate Professor
Unit for Laboratory Animal Medicine
Department of Microbiology and Immunology
and Center for Computational Medicine and Bioinformatics
University of Michigan Medical School
Ann Arbor, MI 48109
Email: yon...@me...<mailto:yon...@me...>
Tel: 734-615-8231 (O)
http://www.hegroup.org/

**********************************************************
Electronic Mail is not secure, may not be read every day, and should not be used for urgent or sensitive issues